Xeloda and Abraxane for pancreatic cancer – pro
Most investigation of Xeloda in pancreatic cancer focused on combining it with gemcitabine. Less is know about combining it with Abraxane. In 2009, Abraxane for Injectable Suspension (paclitaxel albumin [human]-bound particles for injectable suspension) was granted orphan status for the treatment of pancreatic cancer and Stage IIB-IV melanoma. An orphan designation means only that the FDA sees a need to investigate a drug for a specified indication.
Read more